Cargando…

Endothelin ET(A) receptors predominate in chronic thromboembolic pulmonary hypertension

AIMS: Endothelin-1 levels are raised in chronic thromboembolic pulmonary hypertension. Our aim in this study was to identify the presence of endothelin receptors in patients with CTEPH by analysing tissue removed at pulmonary endarterectomy. MAIN METHODS: Pulmonary endarterectomy tissue cross-sectio...

Descripción completa

Detalles Bibliográficos
Autores principales:	Southwood, Mark, MacKenzie Ross, Robert V., Kuc, Rhoda E., Hagan, Guy, Sheares, Karen K., Jenkins, David P., Goddard, Martin, Davenport, Anthony P., Pepke-Zaba, Joanna
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier 2016
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5000546/ https://www.ncbi.nlm.nih.gov/pubmed/26874031 http://dx.doi.org/10.1016/j.lfs.2016.02.036

Ejemplares similares

(18)FDG PET imaging can quantify increased cellular metabolism in pulmonary arterial hypertension: A proof-of-principle study
por: Hagan, Guy, et al.
Publicado: (2011)

Lifting the fog in intermediate-risk (submassive) PE: full dose, low dose, or no thrombolysis?
por: Bhamani, Amyn, et al.
Publicado: (2019)

Maximal Cardiac Output Determines 6 Minutes Walking Distance in Pulmonary Hypertension
por: Deboeck, Gaël, et al.
Publicado: (2014)

Balloon pulmonary angioplasty for inoperable chronic thromboembolic pulmonary hypertension: the UK experience
por: Hoole, Stephen P, et al.
Publicado: (2020)

Pulmonary arterial size and response to sildenafil in chronic thromboembolic pulmonary hypertension
por: Toshner, Mark R., et al.
Publicado: (2010)

The prognostic ability of cardiac output determined by inert gas rebreathing technique in pulmonary hypertension
por: Robertson, Lucy, et al.
Publicado: (2022)

Chronic thromboembolic pulmonary hypertension: time for research in pathophysiology to catch up with developments in treatment
por: Toshner*, Mark, et al.
Publicado: (2014)

Medical management of chronic thromboembolic pulmonary hypertension
por: Pepke-Zaba, Joanna, et al.
Publicado: (2017)

Trans-myocardial Extraction of Endothelin-1 Correlates with Increased Microcirculatory Resistance following Percutaneous Coronary Intervention
por: Abraham, George R., et al.
Publicado: (2022)

Isolated large vessel pulmonary vasculitis as a cause of chronic obstruction of the pulmonary arteries
por: Hagan, Guy, et al.
Publicado: (2011)

Endothelin-1 is increased in the plasma of patients hospitalised with Covid-19
por: Abraham, George R., et al.
Publicado: (2022)

Modulation of endothelin receptors in the failing right ventricle of the heart and vasculature of the lung in human pulmonary arterial hypertension
por: Kuc, Rhoda E., et al.
Publicado: (2014)

Quality of life in patients with chronic thromboembolic pulmonary hypertension
por: Mathai, Stephen C., et al.
Publicado: (2016)

Author's reply
por: Pepke-Zaba, Joanna
Publicado: (2012)

The ADAMTS13–VWF axis is dysregulated in chronic thromboembolic pulmonary hypertension
por: Newnham, Michael, et al.
Publicado: (2019)

Log-transformation improves the prognostic value of serial NT-proBNP levels in apparently stable pulmonary arterial hypertension
por: Soon, Elaine, et al.
Publicado: (2011)

Endothelin Receptors and Their Antagonists()()
por: Maguire, Janet J., et al.
Publicado: (2015)

Endothelin
por: Davenport, Anthony P., et al.
Publicado: (2016)

Estimation of endothelin-mediated vasoconstriction in acute pulmonary thromboembolism
por: Tsang, John Y. C., et al.
Publicado: (2012)

Smooth Muscle Endothelin B Receptors Regulate Blood Pressure but Not Vascular Function or Neointimal Remodeling
por: Miller, Eileen, et al.
Publicado: (2017)

A minimal clinically important difference measured by the Cambridge Pulmonary Hypertension Outcome Review for patients with idiopathic pulmonary arterial hypertension
por: Bunclark, Katherine, et al.
Publicado: (2021)

Mechanistic study of the effect of Endothelin SNPs in microvascular angina – Protocol of the PRIZE Endothelin Sub-Study
por: Abraham, George R., et al.
Publicado: (2022)

Demographics, clinical characteristics, health resource utilization and cost of chronic thromboembolic pulmonary hypertension patients: retrospective results from six European countries
por: Schweikert, Bernd, et al.
Publicado: (2014)

COVID-19 in pulmonary arterial hypertension and chronic thromboembolic pulmonary hypertension: a reference centre survey
por: Belge, Catharina, et al.
Publicado: (2020)

Plasma metabolomics exhibit response to therapy in chronic thromboembolic pulmonary hypertension
por: Swietlik, Emilia M., et al.
Publicado: (2021)

Acute lung injury after balloon pulmonary angioplasty results in a similar haemodynamic response and possible clinical advantage at follow‐up
por: Rodgers, Matthew S., et al.
Publicado: (2022)

Cheating the CHA(2)DS(2)-VASc Score: Thromboembolism in Apical Hypertrophic Cardiomyopathy
por: Weir, Robin A. P., et al.
Publicado: (2014)

Medication and patient factors associated with adherence to pulmonary hypertension targeted therapies
por: Grady, Duncan, et al.
Publicado: (2017)

Highlights from the International Chronic Thromboembolic Pulmonary Hypertension Congress 2021
por: Simonneau, Gérald, et al.
Publicado: (2023)

Plasma Pro‐Endothelin‐1 Peptide Concentrations Rise in Chronic Kidney Disease and Following Selective Endothelin A Receptor Antagonism
por: Dhaun, Neeraj, et al.
Publicado: (2015)

Current strategies for managing chronic thromboembolic pulmonary hypertension: results of the worldwide prospective CTEPH Registry
por: Guth, Stefan, et al.
Publicado: (2021)

The resistance-compliance product of the pulmonary circulation varies in health and pulmonary vascular disease
por: Hadinnapola, Charaka, et al.
Publicado: (2015)

Ventriculo‐arterial coupling detects occult RV dysfunction in chronic thromboembolic pulmonary vascular disease
por: Axell, Richard G., et al.
Publicado: (2017)

Balloon pulmonary angioplasty outcomes in patients previously treated by pulmonary endarterectomy surgery are inferior to those of inoperable patients
por: Kirkby, Louise C., et al.
Publicado: (2023)

Reduced circulating BMP10 and BMP9 and elevated endoglin are associated with disease severity, decompensation and pulmonary vascular syndromes in patients with cirrhosis
por: Owen, Nicola E., et al.
Publicado: (2020)

The impact of patient choice on survival in chronic thromboembolic pulmonary hypertension
por: Quadery, Syed Rehan, et al.
Publicado: (2018)

Distortion of K(B) estimates of endothelin‐1 ET(A) and ET(B) receptor antagonists in pulmonary arteries: Possible role of an endothelin‐1 clearance mechanism
por: Angus, James A., et al.
Publicado: (2017)

Correlation between Saliva and Plasma Levels of Endothelin Isoforms ET-1, ET-2, and ET-3
por: Gurusankar, Roma, et al.
Publicado: (2015)

Endothelin@25 – new agonists, antagonists, inhibitors and emerging research frontiers: IUPHAR Review 12
por: Maguire, J J, et al.
Publicado: (2014)

A novel cyclic biased agonist of the apelin receptor, MM07, is disease modifying in the rat monocrotaline model of pulmonary arterial hypertension
por: Yang, Peiran, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_1ae2c2mgdarq2mioim6ru7spoc